Tina Albertson's most recent trade in Caribou Biosciences Inc was a trade of 66,137 Option to purchase Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caribou Biosciences Inc | Tina Albertson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 66,137 | 66,137 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Tina Albertson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 14,589 | 14,589 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Tina Albertson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 700,000 | 700,000 | - | - | Option (right to buy) |